The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy

Supportive Care in Cancer

Volumn 16, Issue 4, 2008, Pages 359-370

  Tassinari, Davide ^a,i   Montanari, Luigi ^b   Maltoni, Marco ^c   Ballardini, Michela ^d   Piancastelli, Alessandra ^d   Musi, Marco ^e   Porzio, Giampiero ^f   Minotti, Vincenzo ^g   Caraceni, Augusto ^h   Poggi, Barbara ^a   Stella, Anna ^e   Aielli, Federica ^f   Scarpi, Emanuela ^d  

^a City Hospital   (Italy)

^b Umberto I Hospital   (Italy)

^c Palliative Care Unit   (Italy)

^d ISTITUTO ONCOLOGICO ROMAGNOLO   (Italy)

^e General Hospital   (Italy)

^f UNIVERSITY OF L'AQUILA   (Italy)

^g ASLnZ   (Italy)

^h NATIONAL CANCER INSTITUTE   (Italy)

ⁱ NONE   (Italy)

Author keywords

Metastatic cancer; Nonsmall cell lung cancer; Palliative prognostic score

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DYSPNEA; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; LOG RANK TEST; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PALLIATIVE PROGNOSTIC SCORE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RATING SCALE; SCORING SYSTEM; SOLID TUMOR; SYMPTOM DISTRESS SCALE; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PALLIATIVE CARE; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TERMINAL CARE;

EID: 43449115428     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-007-0302-3     Document Type: Article

References (42)

1. Baile WF, Beale EA (2001) Giving bad news to cancer patients: matching process and content. J Clin Oncol 19:2575-2577
2. Ballatori E, Del Favero A, Roila F (1998) Clinical benefit as a primary efficacy end point. J Clin Oncol 16:803-804
3. Barr TR, Jordan WM, Bichkoff HD, Cleland RM (2005) Oncology business management issues in the changing reimbursement enviroment. ASCO 2005 Educational Book 921-927
4. Browner I, Carducci MA (2005) Palliative chemotherapy: historical perspective, applications and controversies. Semin Oncol 32:145-155
5. Bruera E, Kuehn N, Miller M et al (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6-9
6. Bruzzi P, Del Mastro L, Sormani MP et al (2005) Objective response to chemotherapy as a potential surrogate end point of survical in metastatic breast cancer patients. J Clin Oncol 23:5117-5125
7. Burris III HA, Moore MJ, Andersen J et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403-2413
8. Buyse M, Thirion P, Carlson RW et al (2000) Relation between tumor response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Lancet 356:373-378
9. Caraceni A, De Conno F (1998) Analgesic effects of chemotherapy? J Clin Oncol 16:803
10. Chang VT, Hwang SS, Feuerman M (2000) Validation of the Edmonton symptom assessment scale. Cancer 88:2164-2171
11. Cherny NI (2003) European Society of Medical Oncology (ESMO) joints the palliative care community. Palliat Med 17:475-476
12. Cherny NI, Catane R (2003) Attitudes of medical oncologists toward palliative care for patients with advanced and incurable cancer. Cancer 98:2502-2510
13. Cherny NI, Catane R, Kosmidis P (2003) ESMO takes a stand on supportive and palliative care. Ann Oncol 14:1335-1337
14. Christakis NA, Lamont EB (2000) Extent and determinants of error in doctors'prognoses in terminally ill patients: prospective cohort study. BMJ 320:469-473
15. Earle CC, Neville BA, Landrum MB et al (2004) Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 22:315-321
16. Earle CC, Park ER, Lai B et al (2003) Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol 21:1133-1138
17. Gagnon B, Mayo NE, MacDonald N n (2004) Pattern of care at the end of life: does age make a difference in what happens to women with breast cancer? J Clin Oncol 22:3458-3465
18. Geels P, Eisenhauer E, Bezjak A, Zee B, Day A (2000) Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. J Clin Oncol 18: 2395-2405
19. Glare P, Virik K (2001) Independent prospective validation of the PaP score in terminally ill patients referred to a hospital-based palliative medicine consultation service. J Pain Symptom Manage 22:891-898
20. Glare PA, Eychmueller S, McMahon P (2004) Diagnostic accuracy of the palliative prognostic score in hospitalized patients with advanced cancer. J Clin Oncol 22:4823-4828
21. Glare P, Virik K, Jones M et al (2003) A systematic review of physicians survival prediction in terminally ill cancer patients. BMJ 327:195-198
22. Gorodokin GI, Novic AA (2005) Quality of cancer care. Ann Oncol 16:991
23. Lamont EB, Christakis NA (2003) Complexities in prognostication in advanced cancer. "To help them live their lives the way they want to". JAMA 290:98-104
24. Mailin JL, Geffen D (2004) Bridging the divide: integrating cancer directed therapies and palliative care. J Clin Oncol 22:3438-3440
25. Maltoni M, Amadori D (2002) Prognosis in advanced cancer. Hematol Oncol Clin N Am 16:715-729
26. Maltoni M, Tassinari D (2004) Prognostic assessment in terminally ill cancer patients: from evidence-based knowledge to a patient-physician relationship and back. Palliat Med 18:77-79
27. Maltoni M, Caraceni A, Brunelli C et al (2005) Prognostic factors in advanced cancer patients: evidence-based clinical recommendations. A study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 23:6240-6248
28. Maltoni M, Nanni O, Pirovano et al (1999) Successful validation of the Palliative Prognostic Score in terminally ill cancer patients: Italian Multicenter and Study Group on Palliative Care. J Pain Symptom Manage 17:240-247
29. Meropol NJ, Desmond-Hellmann S, Tunis S, Schulman KA (2005) Can society affort state of the art cancer treatment? American Society of Clinical Oncology 2005 Educational Book 473-480
30. Pirovano M, Maltoni M, Nanni O et al (1999) A new palliative prognostic Score: A first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care. J Pain Symptom Manage 17:231-239
31. Schneider EC, Epstein AM, Malin JL et al (2004) Developing a system to assess the quality of cancer care: ASCO's national initiative on cancer quality of care. J Clin Oncol 22:2985-2991
32. Shanafelt TD, Loprinzi CL, Marks R et al (2004) Are chemotherapy response rate related to treatment-induced survival prolongations in patients with advanced cancer? J Clin Oncol 22:1966-1974
33. Silvestri G, Pritchard R, Welch HG (1998) Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. BMJ 317:771-775
34. Tassinari D, Papi M, Fochessati F et al (2004) Outcomes of palliative chemotherapy in stage in non-small-cell lung cancer. Have we found what we are looking for? Lung Cancer 43:373-374
35. Tassinari D, Poggi B, Fantini M, Nicoletti SVL, Sartori S (2005) Quality of care at the end of life: how far are we from reaching a comprehensive solution to the problem? Palliat Med 19:434-435
36. Vardy J, Tannock IF (2004) Quality of cancer care. Ann Oncol 15:1001-1006
37. Vigano A, Dorgan M, Bruera E, Suarez-Almazor ME (1999) The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer. Cancer 86:170-176
38. Viganò A, Dorgan M, Buckingham J, Bruera E, Suarez-Almozor ME (2000) Survival prediction in terminal cancer patients: a systematic review of the medical literature. Palliat Med 14:363-374
39. Voogt E, van-der-Heide A, Rietjens JAC et al (2005) Attitudes of patients with incurable cancer toward medical treatment in the last phase of life. J Clin Oncol 23:2012-2019
40. Yabroff KR, Mandelblatt JS, Ingham J (2004) The quality of medical care at the end of life in the USA: existing barriers and examples of process and outcome measures. Palliat Med 18:202-216
41. Weeks JC, Cook EF, O'Day SJ et al (1998) Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 279:1709-1714
42. Weissman DE (2004) Decision making at the time of crisis near the end of live. JAMA 292:1738-1743